Avonex (interferon beta-1a), the new treatment for multiple sclerosis (MS)

There's a lot of excitement about Avonex (interferon beta-1a), the new treatment for multiple sclerosis (MS).

Avonex is a beta-interferon...but it's chemically different from the other MS treatment, Betaseron (interferon beta-1b). That might explain some of the differences in their effects.

Both Avonex and Betaseron reduce the frequency of attacks in patients with the relapsing forms of MS.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote